BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27406771)

  • 1. [ManNAc, a new therapeutic agent to reduce Angptl4-induced proteinuria in MCD].
    Clément L; Macé C
    Med Sci (Paris); 2016; 32(6-7):606-11. PubMed ID: 27406771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
    Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
    Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into human minimal change disease: lessons from animal models.
    Chugh SS; Clement LC; Macé C
    Am J Kidney Dis; 2012 Feb; 59(2):284-92. PubMed ID: 21974967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease.
    Li JS; Chen X; Peng L; Wei SY; Zhao SL; Diao TT; He YX; Liu F; Wei QJ; Zhang QF; Li B
    PLoS One; 2015; 10(9):e0137049. PubMed ID: 26352670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
    Chugh SS; Clement LC
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-like-4 and minimal change disease.
    Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
    PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtering new facts about kidney disease.
    Reiser J
    Nat Med; 2011 Jan; 17(1):44-5. PubMed ID: 21217681
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic effect of the NPHS2 gene variants on proteinuria in minimal change disease and immunoglobulin A nephropathy.
    Zhu L; Yu L; Wang CD; Lv JC; Li GS; Zhang H; Wang HY
    Nephrology (Carlton); 2009 Dec; 14(8):728-34. PubMed ID: 20025681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
    Clement LC; Macé C; Avila-Casado C; Joles JA; Kersten S; Chugh SS
    Nat Med; 2014 Jan; 20(1):37-46. PubMed ID: 24317117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.
    Galeano B; Klootwijk R; Manoli I; Sun M; Ciccone C; Darvish D; Starost MF; Zerfas PM; Hoffmann VJ; Hoogstraten-Miller S; Krasnewich DM; Gahl WA; Huizing M
    J Clin Invest; 2007 Jun; 117(6):1585-94. PubMed ID: 17549255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.
    Cara-Fuentes G; Clapp WL; Johnson RJ; Garin EH
    Pediatr Nephrol; 2016 Dec; 31(12):2179-2189. PubMed ID: 27384691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C; Petrini C; Rizza V; Arrigo G; D'Amico G
    Kidney Int; 2000 Oct; 58(4):1732-41. PubMed ID: 11012907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.
    Macé C; Chugh SS
    J Am Soc Nephrol; 2014 Nov; 25(11):2393-8. PubMed ID: 24854282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrotic syndrome: therapeutic possibilities].
    Gans RO
    Ned Tijdschr Geneeskd; 1991 Dec; 135(50):2375-9. PubMed ID: 1749442
    [No Abstract]   [Full Text] [Related]  

  • 16. [Renal function in subjects with minimal change steroid-responsive nephrotic syndrome in childhood].
    Strzelecka-Lichota A
    Ann Acad Med Stetin; 2004; 50(2):41-9. PubMed ID: 16529164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric nephrotic syndrome: from the simple to the complex.
    Lane JC; Kaskel FJ
    Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S; Tojo A; Sakai T; Tsumura H; Takahashi M; Hirata Y; Fujita T
    Kidney Int; 2011 Dec; 80(12):1328-38. PubMed ID: 21849973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of Angptl4 in nephrotic syndrome: a two-faced protein].
    Macé C; Clément LC
    Med Sci (Paris); 2014; 30(6-7):605-7. PubMed ID: 25014443
    [No Abstract]   [Full Text] [Related]  

  • 20. Early posttransplant nephrotic range proteinuria as a presenting feature of minimal change disease and acute T cell-mediated rejection.
    Nongnuch A; Assanatham M; Sumethkul V; Chalermsanyakorn P; Kitiyakara C
    Transplant Proc; 2014; 46(1):290-4. PubMed ID: 23267783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.